Locust Walk Acquisition Corp. (LWAC) Shareholders Approve eFFECTOR Therapeutics Deal With Heavy Redemptions

Locust Walk Acquisition Corp. (NASDAQ:LWAC) announced in a press release today that its shareholders approved its combination with biopharmaceutical firm eFFECTOR, but roughly 97% of shareholders also opted to redeem in connection with the vote. LWAC shareholders redeemed 16,978,642 of its outstanding shares, which leaves just $5.2 million in its trust account. Combined with the
Read More